Inovio Pharmaceuticals Net Income 2006-2020 | INO

Inovio Pharmaceuticals net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Inovio Pharmaceuticals Annual Net Income
(Millions of US $)
2020 $-166
2019 $-119
2018 $-97
2017 $-88
2016 $-74
2015 $-29
2014 $-36
2013 $-66
2012 $-20
2011 $-15
2010 $-18
2009 $-24
2008 $-13
2007 $-11
2006 $-14
2005 $-26
Inovio Pharmaceuticals Quarterly Net Income
(Millions of US $)
2020-12-31 $-24
2020-09-30 $19
2020-06-30 $-129
2020-03-31 $-33
2019-12-31 $-38
2019-09-30 $-23
2019-06-30 $-29
2019-03-31 $-29
2018-12-31 $-33
2018-09-30 $-25
2018-06-30 $-7
2018-03-31 $-32
2017-12-31 $-22
2017-09-30 $-34
2017-06-30 $-9
2017-03-31 $-23
2016-12-31 $-26
2016-09-30 $-21
2016-06-30 $-19
2016-03-31 $-8
2015-12-31 $-18
2015-09-30 $6
2015-06-30 $-6
2015-03-31 $-11
2014-12-31 $-7
2014-09-30 $-7
2014-06-30 $-11
2014-03-31 $-11
2013-12-31 $-15
2013-09-30 $-31
2013-06-30 $-11
2013-03-31 $-9
2012-12-31 $-1
2012-09-30 $-7
2012-06-30 $-4
2012-03-31 $-8
2011-12-31 $-5
2011-09-30 $-5
2011-06-30 $-3
2011-03-31 $-2
2010-12-31 $-6
2010-09-30 $-1
2010-06-30 $-8
2010-03-31 $-2
2009-12-31 $-7
2009-09-30 $-3
2009-06-30 $-11
2009-03-31 $-3
2008-12-31 $-4
2008-09-30 $-2
2008-06-30 $-4
2008-03-31 $-3
2007-12-31 $-1
2007-09-30 $-3
2007-06-30 $-4
2007-03-31 $-4
2006-12-31 $-8
2006-09-30 $-3
2006-06-30 $-3
2006-03-31
2005-12-31 $-12
2005-09-30 $-3
2005-06-30 $-2
2005-03-31 $-9
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.819B $0.007B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.922B 15.06
Bristol Myers Squibb (BMY) United States $142.033B 9.87
CSL (CSLLY) Australia $92.235B 0.00
Gilead Sciences (GILD) United States $81.700B 9.15
Moderna (MRNA) United States $59.963B 0.00
Illumina (ILMN) United States $58.820B 89.59
Vertex Pharmaceuticals (VRTX) United States $55.890B 23.86
Regeneron Pharmaceuticals (REGN) United States $51.106B 16.70
Biogen (BIIB) United States $40.550B 8.11
Alexion Pharmaceuticals (ALXN) United States $33.797B 13.16
BioNTech SE (BNTX) Germany $31.311B 810.25
BeiGene (BGNE) Cayman Islands $27.539B 0.00
Seagen (SGEN) United States $25.544B 43.76
Genmab (GMAB) Denmark $22.726B 31.79
Exact Sciences (EXAS) United States $21.644B 0.00
Genmab (GNMSF) Denmark $21.134B 5.01
Horizon Therapeutics Public (HZNP) Ireland $20.530B 23.55
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.932B 57.06
Incyte (INCY) United States $17.730B 0.00
Bio-Techne Corp (TECH) United States $16.274B 93.21
Alnylam Pharmaceuticals (ALNY) United States $15.983B 0.00
Guardant Health (GH) United States $15.751B 0.00
Novavax (NVAX) United States $14.377B 0.00
Zai Lab (ZLAB) China $14.289B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.141B 112.71
ARGENX SE-ADR (ARGX) Netherlands $13.800B 0.00
QIAGEN (QGEN) Netherlands $11.862B 24.20
Repligen (RGEN) United States $11.659B 128.23
CRISPR Therapeutics AG (CRSP) Switzerland $9.118B 0.00
Mirati Therapeutics (MRTX) United States $8.091B 0.00
AbCellera Biologics (ABCL) $7.616B 0.00
Acceleron Pharma (XLRN) United States $7.462B 0.00
Fate Therapeutics (FATE) United States $7.400B 0.00
Exelixis (EXEL) United States $7.307B 66.91
Ultragenyx Pharmaceutical (RARE) United States $7.136B 0.00
Twist Bioscience (TWST) United States $6.850B 0.00
Ascendis Pharma (ASND) Denmark $6.709B 0.00
Denali Therapeutics (DNLI) United States $6.540B 207.92
Halozyme Therapeutics (HALO) United States $6.374B 49.42
Adaptive Biotechnologies (ADPT) United States $6.041B 0.00
NeoGenomics (NEO) United States $5.795B 707.29
Vir Biotechnology (VIR) United States $5.744B 0.00
Sarepta Therapeutics (SRPT) United States $5.559B 0.00
Blueprint Medicines (BPMC) United States $5.395B 17.76
Galapagos (GLPG) Belgium $5.130B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.086B 15.99
Intellia Therapeutics (NTLA) United States $4.794B 0.00
Atea Pharmaceuticals (AVIR) United States $4.734B 0.00
Beam Therapeutics (BEAM) United States $4.673B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $4.515B 0.00
Certara (CERT) United States $4.234B 0.00
Arena Pharmaceuticals (ARNA) United States $4.006B 0.00
Emergent Biosolutions (EBS) United States $3.898B 9.27
I-Mab (IMAB) China $3.571B 0.00
Legend Biotech (LEGN) United States $3.519B 0.00
Seer (SEER) $3.467B 0.00
SpringWorks Therapeutics (SWTX) United States $3.399B 0.00
Apellis Pharmaceuticals (APLS) United States $3.395B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.297B 0.00
Insmed (INSM) United States $3.272B 0.00
Berkeley Lights (BLI) United States $3.233B 0.00
Reata Pharmaceuticals (RETA) United States $3.130B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.022B 42.81
Alkermes (ALKS) Ireland $3.003B 0.00
Arvinas (ARVN) United States $2.998B 0.00
MorphoSys AG (MOR) Germany $2.942B 44.72
Editas Medicine (EDIT) United States $2.806B 0.00
Vericel (VCEL) United States $2.609B 1132.00
Intra-Cellular Therapies (ITCI) United States $2.511B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.503B 0.00
Global Blood Therapeutics (GBT) United States $2.497B 0.00
Amicus Therapeutics (FOLD) United States $2.461B 0.00
Ligand Pharmaceuticals (LGND) United States $2.442B 46.23
Arcus Biosciences (RCUS) United States $2.300B 0.00
ALX Oncology Holdings (ALXO) United States $2.291B 0.00
Myriad Genetics (MYGN) United States $2.129B 0.00
PHARMA MAR SA (PHMMF) Spain $2.055B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.048B 0.00
Amarin (AMRN) Ireland $1.999B 0.00
Revance Therapeutics (RVNC) United States $1.984B 0.00
Sorrento Therapeutics (SRNE) United States $1.946B 0.00
Seres Therapeutics (MCRB) United States $1.923B 0.00
Bionano Genomics (BNGO) United States $1.920B 0.00
Bluebird Bio (BLUE) United States $1.902B 0.00
Heska (HSKA) United States $1.882B 0.00
NGM Biopharmaceuticals (NGM) United States $1.874B 0.00
Morphic Holding (MORF) United States $1.871B 0.00
Genetron Holdings (GTH) China $1.777B 0.00
Five Prime Therapeutics (FPRX) United States $1.767B 0.00
Castle Biosciences (CSTL) United States $1.713B 0.00
Cytokinetics (CYTK) United States $1.710B 0.00
Sangamo Therapeutics (SGMO) United States $1.621B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.619B 0.00
UniQure (QURE) Netherlands $1.569B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.566B 0.00
Codexis (CDXS) United States $1.559B 0.00
Travere Therapeutics (TVTX) United States $1.513B 0.00
Keros Therapeutics (KROS) United States $1.490B 0.00
REGENXBIO (RGNX) United States $1.473B 0.00
Precigen (PGEN) United States $1.456B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.423B 0.00
Zealand Pharma (ZEAL) Denmark $1.423B 0.00
Alector (ALEC) United States $1.395B 0.00
Kymera Therapeutics (KYMR) United States $1.393B 0.00
MiMedx (MDXG) United States $1.380B 0.00
Cara Therapeutics (CARA) United States $1.371B 343.63
C4 Therapeutics (CCCC) United States $1.362B 0.00
Shattuck Labs (STTK) United States $1.341B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.312B 0.00
Zymeworks (ZYME) Canada $1.289B 0.00
Ocugen (OCGN) United States $1.262B 0.00
Repare Therapeutics (RPTX) Canada $1.200B 0.00
Nurix Therapeutics (NRIX) United States $1.177B 0.00
Northwest Biotherapeutics (NWBO) United States $1.176B 0.00
Avid Bioservices (CDMO) United States $1.170B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Nkarta (NKTX) United States $1.165B 0.00
Dynavax Technologies (DVAX) United States $1.128B 0.00
Mesoblast (MESO) Australia $1.121B 0.00
Protagonist Therapeutics (PTGX) United States $1.120B 0.00
Mersana Therapeutics (MRSN) United States $1.116B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.113B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.093B 0.00
Pliant Therapeutics (PLRX) United States $1.081B 0.00
MannKind (MNKD) United States $1.049B 0.00
Curis (CRIS) United States $1.041B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.037B 0.00
G1 THERAPEUTICS (GTHX) United States $1.019B 0.00
Coherus BioSciences (CHRS) United States $1.018B 8.24
Syndax Pharmaceuticals (SNDX) United States $0.994B 0.00
Scholar Rock Holding (SRRK) United States $0.970B 0.00
Prothena (PRTA) Ireland $0.935B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.895B 37.93
Adverum Biotechnologies (ADVM) United States $0.882B 0.00
Sutro Biopharma (STRO) United States $0.879B 0.00
Affimed (AFMD) Germany $0.874B 0.00
Merus (MRUS) Netherlands $0.863B 0.00
Celldex Therapeutics (CLDX) United States $0.851B 0.00
Pharming Group (PHAR) Netherlands $0.846B 0.00
Inhibrx (INBX) United States $0.841B 0.00
Epizyme (EPZM) United States $0.833B 0.00
Cellectis S.A (CLLS) France $0.831B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.824B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
KaloBios Pharmaceuticals (HGEN) United States $0.813B 0.00
Bolt Biotherapeutics (BOLT) United States $0.798B 0.00
Prometheus Biosciences (RXDX) United States $0.793B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.788B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.751B 0.00
Avidity Biosciences (RNA) United States $0.748B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.727B 0.00
VBI Vaccines (VBIV) United States $0.724B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.699B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.677B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.649B 0.00
DBV Technologies S.A (DBVT) France $0.647B 0.00
Clovis Oncology (CLVS) United States $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Cel-Sci (CVM) United States $0.638B 0.00
ALBIREO PHARMA (ALBO) United States $0.623B 0.00
Kadmon Holdings (KDMN) United States $0.622B 0.00
Starpharma Holdings (SPHRY) Australia $0.609B 0.00
ChromaDex (CDXC) United States $0.603B 0.00
MeiraGTx Holdings (MGTX) United States $0.602B 0.00
Compugen (CGEN) Israel $0.597B 0.00
IDEAYA Biosciences (IDYA) United States $0.584B 0.00
Adagene (ADAG) $0.583B 0.00
Anika Therapeutics (ANIK) United States $0.579B 192.48
AnaptysBio (ANAB) United States $0.561B 0.00
Agenus (AGEN) United States $0.555B 0.00
Inventiva S.A (IVA) France $0.540B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.539B 0.00
AMMO (POWW) United States $0.518B 0.00
Neoleukin Therapeutics (NLTX) United States $0.517B 0.00
Amryt Pharma (AMYT) United Kingdom $0.492B 0.00
XBiotech (XBIT) United States $0.491B 0.00
Precision BioSciences (DTIL) United States $0.490B 0.00
AC Immune SA (ACIU) Switzerland $0.480B 0.00
RAPT THERAPTICS (RAPT) United States $0.480B 0.00
Forte Biosciences (FBRX) United States $0.468B 0.00
Fortress Biotech (FBIO) United States $0.468B 0.00
Verastem (VSTM) United States $0.464B 0.00
Geron (GERN) United States $0.456B 0.00
CytomX Therapeutics (CTMX) United States $0.442B 0.00
Kala Pharmaceuticals (KALA) United States $0.441B 0.00
Selecta Biosciences (SELB) United States $0.438B 0.00
AquaBounty Technologies (AQB) United States $0.438B 0.00
Opthea (OPT) Australia $0.434B 0.00
Gritstone Oncology (GRTS) United States $0.433B 0.00
XOMA (XOMA) United States $0.423B 93.82
Angion Biomedica (ANGN) United States $0.421B 0.00
ANI Pharmaceuticals (ANIP) United States $0.408B 11.39
Adicet Bio (ACET) United States $0.404B 0.00
SESEN BIO, INC (SESN) United States $0.395B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.394B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.390B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
Seelos Therapeutics (SEEL) United States $0.386B 0.00
Spero Therapeutics (SPRO) United States $0.384B 0.00
Puma Biotechnology (PBYI) United States $0.382B 0.00
Fulcrum Therapeutics (FULC) United States $0.376B 0.00
Athersys (ATHX) United States $0.372B 0.00
Athenex (ATNX) United States $0.372B 0.00
UROGEN PHARMA (URGN) United States $0.365B 0.00
SQZ Biotechnologies (SQZ) United States $0.363B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.363B 0.00
Theratechnologies (THTX) Canada $0.359B 0.00
CorMedix Inc (CRMD) United States $0.356B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.355B 0.00
Cue Biopharma (CUE) United States $0.354B 0.00
Oncobiologics (OTLK) United States $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.348B 13.80
Frequency Therapeutics (FREQ) United States $0.348B 0.00
Bellus Health (BLU) Canada $0.343B 0.00
Innate Pharma S.A (IPHA) France $0.340B 0.00
HOOKIPA Pharma (HOOK) United States $0.324B 0.00
Cardiff Oncology (CRDF) United States $0.321B 0.00
Cogent Biosciences (COGT) United States $0.320B 0.00
WAVE Life Sciences (WVE) Singapore $0.316B 0.00
IBio (IBIO) United States $0.315B 0.00
Arbutus Biopharma (ABUS) United States $0.305B 0.00
Kaleido Biosciences (KLDO) $0.302B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.302B 0.00
Codiak BioSciences (CDAK) United States $0.300B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.291B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.280B 0.00
Trevena (TRVN) United States $0.279B 0.00
VTv Therapeutics (VTVT) United States $0.277B 0.00
Kamada (KMDA) Israel $0.268B 15.46
Protalix BioTherapeutics (PLX) Israel $0.258B 0.00
NextCure (NXTC) United States $0.256B 0.00
OVID THERAPEUTC (OVID) United States $0.241B 0.00
Cerecor (CERC) United States $0.233B 0.00
Prima BioMed (IMMP) Australia $0.232B 0.00
Checkpoint Therapeutics (CKPT) United States $0.216B 0.00
ADMA Biologics Inc (ADMA) United States $0.207B 0.00
LogicBio Therapeutics (LOGC) United States $0.205B 0.00
Kindred Biosciences (KIN) United States $0.204B 0.00
TELA Bio (TELA) United States $0.201B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
Aptinyx (APTX) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.186B 0.00
VolitionRX (VNRX) United States $0.182B 0.00
Eton Pharmaceuticals (ETON) United States $0.181B 0.00
Nicox SA (NICXF) France $0.176B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.175B 0.00
Voyager Therapeutics (VYGR) United States $0.173B 4.84
DiaMedica Therapeutics (DMAC) United States $0.173B 0.00
Applied Genetic Technologies (AGTC) United States $0.171B 0.00
Exicure (XCUR) United States $0.170B 0.00
Strongbridge Biopharma (SBBP) United States $0.168B 0.00
INmune Bio (INMB) United States $0.168B 0.00
Antibe Therapeutics (ATBPF) Canada $0.167B 0.00
Chiasma (CHMA) United States $0.167B 0.00
ObsEva SA (OBSV) Switzerland $0.163B 0.00
Enzo Biochem (ENZ) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.160B 0.00
Catalyst Biosciences (CBIO) United States $0.157B 0.00
Abeona Therapeutics (ABEO) United States $0.153B 0.00
Clearside Biomedical (CLSD) United States $0.151B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.148B 0.00
X4 Pharmaceuticals (XFOR) United States $0.147B 0.00
Erytech Pharma SA (ERYP) France $0.144B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Pluristem Therapeutics (PSTI) Israel $0.141B 0.00
Eyenovia (EYEN) United States $0.141B 0.00
Evofem Biosciences (EVFM) United States $0.139B 0.00
Palatin Technologies (PTN) United States $0.136B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.133B 0.00
Synlogic (SYBX) United States $0.132B 0.00
Orgenesis (ORGS) United States $0.130B 267.00
Liminal BioSciences (LMNL) Canada $0.129B 0.00
Galena Biopharma (SLS) United States $0.127B 0.00
TRACON Pharmaceuticals (TCON) United States $0.124B 0.00
Aytu BioPharma (AYTU) United States $0.121B 0.00
Evogene (EVGN) Israel $0.117B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.116B 0.00
Novogen (KZIA) Australia $0.115B 0.00
Zosano Pharma (ZSAN) United States $0.114B 0.00
Beyond Air (XAIR) United States $0.111B 0.00
Aptevo Therapeutics (APVO) United States $0.111B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Cleveland BioLabs (CBLI) United States $0.108B 0.00
Ecology Coatings (ABVC) United States $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.105B 0.00
Cidara Therapeutics (CDTX) United States $0.104B 0.00
Leap Therapeutics (LPTX) United States $0.103B 0.00
Celyad SA (CYAD) Belgium $0.097B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Celsion (CLSN) United States $0.095B 0.00
Lumos Pharma (LUMO) United States $0.094B 0.00
Cocrystal Pharma (COCP) United States $0.093B 0.00
Cyclerion Therapeutics (CYCN) United States $0.092B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.088B 0.00
Vascular Biogenics (VBLT) Israel $0.086B 0.00
AIkido Pharma (AIKI) United States $0.084B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.083B 0.00
Adocia (ADOCY) France $0.077B 0.00
CytRx (CYTR) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Purple Biotech (PPBT) Israel $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.070B 0.00
Timber Pharmaceuticals (TMBR) United States $0.070B 0.00
Advaxis (ADXS) United States $0.069B 0.00
BioCardia (BCDA) United States $0.069B 0.00
Emmaus Life Sciences (EMMA) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Genetic Technologies (GENE) Australia $0.064B 0.00
AnPac Bio-Medical Science (ANPC) China $0.063B 0.00
AEterna Zentaris (AEZS) United States $0.060B 0.00
Windtree Therapeutics (WINT) United States $0.060B 0.00
ATyr Pharma (LIFE) United States $0.060B 0.00
ARIDIS PHARMACT (ARDS) United States $0.060B 0.00
Alimera Sciences (ALIM) United States $0.059B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.059B 0.00
ZIVO Bioscience (ZIVO) United States $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
Pulmatrix (PULM) United States $0.055B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.052B 0.00
Enveric Biosciences (ENVB) United States $0.050B 0.00
Happiness Biotech Group (HAPP) China $0.049B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.049B 0.00
Yumanity Therapeutics (YMTX) United States $0.046B 0.00
Cyclo Therapeutics (CYTH) United States $0.045B 0.00
Clene (CLNN) United States $0.043B 0.00
Invo BioScience (INVO) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.042B 0.00
Vyant Bio (VYNT) United States $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.039B 0.59
Sonnet BioTherapeutics Holdings (SONN) United States $0.037B 0.00
GeoVax Labs (GOVX) United States $0.037B 0.00
Vallon Pharmaceuticals (VLON) United States $0.035B 0.00
IMMURON (IMRN) Australia $0.032B 0.00
ThermoGenesis Holdings (THMO) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
Seneca Biopharma (SNCA) United States $0.026B 0.00
Lexaria Bioscience (LEXX) Canada $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Benitec Biopharma (BNTC) United States $0.024B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.009B 0.00
China Biologic Products (CBPO) China $0.000B 29.35
Entera Bio (ENTX) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00